Armstrong Advisory Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$173K Hold
2,027
– – 0.01% 257
2026
Q2
$186K Buy
+2,027
New +$177K 0.01% 259
2026
Q1
– Sell
-16
Closed -$1.26K – 971
2025
Q4
$1.26K Sell
16
-343
-96% -$26.9K ﹤0.01% 898
2025
Q3
$28.7K Hold
359
– – ﹤0.01% 499
2025
Q2
$32.6K Sell
359
-6,730
-95% -$614K ﹤0.01% 462
2025
Q1
$644K Hold
7,089
– – 0.05% 97
2024
Q4
$644K Sell
7,089
-237
-3% -$22.6K 0.05% 97
2024
Q3
$760K Buy
7,326
+174
+2% +$17.7K 0.06% 81
2024
Q2
$694K Buy
7,152
+12
+0.2% +$1.11K 0.06% 83
2024
Q1
$569K Hold
7,140
– – 0.06% 88
2023
Q4
$569K Hold
7,140
– – 0.06% 88
2023
Q3
$508K Hold
7,140
– – 0.06% 85
2023
Q2
$550K Hold
7,140
– – 0.06% 82
2023
Q1
$537K Hold
7,140
– – 0.06% 84
2022
Q4
$563K Buy
+7,140
New +$535K 0.07% 83

Other funds holding CL

Armstrong Advisory Group's CL Position: Q3 2026 in Review

Armstrong Advisory Group held its Colgate-Palmolive (CL) position steady in Q3 2026 at 2,027 shares worth $173K. The position accounts for 0.01% of the portfolio, ranked #257.

Armstrong Advisory Group first reported a position in CL in Q4 2022 and has held it in 15 quarters since. The position peaked at $760K in Q3 2024. 526 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Armstrong Advisory Group held 2,027 shares of Colgate-Palmolive worth $173K as of Q3 2026.
  • Armstrong Advisory Group left its Colgate-Palmolive share count unchanged in Q3 2026.
  • Colgate-Palmolive made up 0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #257 holding.
  • Armstrong Advisory Group first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Colgate-Palmolive position peaked at $760K in Q3 2024.
  • 526 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.